Pine Labs
Market cap ₹19,556 Cr
- P/E
- 121.83
- Day range
- ₹168.84 – ₹172.62
- 52-week range
- ₹134.73 – ₹254.75
- Volume
- 36.74 L
- Open
- ₹171.00
- Prev close
- ₹171.44
Latest results · Q2 FY27(consolidated)Revenue ₹806 Cr+24.0%Profit ₹39 Cr+546.1%Margin 4.8%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
PINELABS in NSE indices and F&O
Research profile
Composite 43 / 100Factor percentiles
Derived metrics
- Earn. yield
- 0.8%
- Graham no.
- ₹40.51
- vs Graham
- -76.1%
- ROE ÷ P/B
- 0.7%
- Piotroski
- 5/6
- FCF yield
- 0.8%
- PEG
- 0.22
Appears in 10 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 68 in NBFC| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Bajaj FinanceBAJFINANCE | ₹6.93 L Cr | 31.45 | 5.64 | 18.4% | 10.9% | — | 4.08 | +22.8% |
| National Stock Exchange of IndiaNSE | ₹5.19 L Cr | 47.30 | 12.25 | 33.0% | 41.0% | 76.0% | 0.01 | +0.9% |
| Bajaj FinservBAJAJFINSV | ₹2.97 L Cr | 28.05 | 3.56 | 26.2% | 11.0% | 40.0% | 5.91 | +16.7% |
| Shriram FinanceSHRIRAMFIN | ₹2.28 L Cr | 16.17 | 2.06 | 16.4% | 11.5% | — | 2.12 | +15.8% |
| Cholamandalam InvestmentCHOLAFIN | ₹1.61 L Cr | 25.69 | 4.59 | 19.3% | 9.7% | — | 6.72 | +23.8% |
| Jio Financial ServicesJIOFIN | ₹1.54 L Cr | 85.36 | 1.15 | 1.2% | 2.0% | 63.0% | 0.32 | +73.2% |
| BSE LtdBSE | ₹1.53 L Cr | 50.20 | 20.19 | 44.8% | 60.0% | 68.0% | 0.00 | +34.2% |
| Pine LabsPINELABS | ₹19,556 Cr | 121.83 | 3.26 | 2.4% | 4.0% | 16.0% | 0.06 | +24.0% |
| Sector median | ₹29,856 Cr | 22.67 | 2.63 | 15.3% | 11.5% | 55.5% | 1.70 | +19.2% |
Sector as classified in the tracked universe; medians use every tracked NBFC company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 11h agoHeadlines about Pine Labs from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 121.0
- Price / Book
- 3.25
- ROE (FY26)
- 2.4%
- ROCE (latest year)
- 4%
- Dividend yield
- 0.00%
Moving averages (NSE)
- 20-day
- ₹162.47
- Price above
- 50-day
- ₹170.38
- Price below
- 200-day
- ₹170.29
- Price below
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Public
- DII
- FII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Financial statements
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 552 | 602 | 599 | 616 | 650 | 744 | 701 | 737 | 806 |
| Expenses | 519 | 525 | 542 | 571 | 575 | 612 | 594 | 642 | 680 |
| Operating Profit | 32 | 77 | 57 | 45 | 75 | 132 | 106 | 95 | 126 |
| OPM % | 6% | 13% | 9% | 7% | 12% | 18% | 15% | 13% | 16% |
| Other Income | 22 | -30 | 12 | 37 | 23 | 23 | 50 | 29 | 26 |
| Interest | 18 | 22 | 22 | 21 | 21 | 24 | 17 | 13 | 14 |
| Depreciation | 75 | 76 | 69 | 65 | 66 | 68 | 71 | 73 | 76 |
| Profit before tax | -38 | -51 | -22 | -5 | 11 | 63 | 68 | 38 | 61 |
| Tax % | -16% | 11% | 30% | -199% | 47% | 32% | 13% | 48% | 37% |
| Net Profit | -32 | -57 | -29 | 5 | 6 | 42 | 59 | 20 | 39 |
| EPS in Rs | ₹-0.30 | ₹-0.54 | ₹-0.27 | ₹0.05 | ₹0.06 | ₹0.37 | ₹0.52 | ₹0.17 | ₹0.33 |
From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
-56 days since Mar 2021
+9 days since Mar 2021
-963 days since Mar 2021
+916 days since Mar 2021
+643 days since Mar 2021
Strengths, risks & growth
Incorporated in 1998, Pine Labs is a leading Indian merchant commerce platform that provides point-of-sale (POS) solutions, payment processing, and merchant financing services. [1]
Strengths
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 32.3% CAGR over last 5 years
Risks
- Stock is trading at 3.26 times its book value
- Company has a low return on equity of -2.94% over last 3 years.
- Company's cost of borrowing seems high
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- +32%
- 3 Years
- +19%
- TTM
- +21%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- +32%
- 3 Years
- +36%
- TTM
- +485%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- 1 Year
- -29%
Return on Equity
- 10 Years
- —
- 5 Years
- -4%
- 3 Years
- -3%
- Last Year
- +2%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| FII | 5.23% | 4.80% | 9.49% | 13.18% | +3.69 pp |
| DII | 11.26% | 11.81% | 24.82% | 29.57% | +4.75 pp |
| Public | 83.51% | 83.39% | 65.68% | 57.24% | -8.44 pp |
Filed with NSE for Sept 2026: promoters 0.00%, public 100.00%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 26.69% (+5.44 pp)- Promoters0.0%
- Foreign institutions13.2%
- Mutual funds26.7%
- Insurance1.9%
- Other domestic institutions1.0%
- Retail9.9%
- Others47.4%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| SBI Small Cap Fund | 4.85% | 2.45% | +0.27 pp |
| Kotak Multi Cap Fund | 1.96% | 1.30% | +1.30 pp |
| Franklin India Small Cap Fund | 1.81% | 2.70% | +0.52 pp |
| Kotak Large & Mid Cap Fund | 1.55% | 1.00% | +1.00 pp |
| Nippon India Small Cap Fund | 1.26% | 0.32% | +0.04 pp |
Scorecard
- Performance
- Low
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 249 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 49.5%
- Downside volatility
- 45.3%
- Worst 5% of days
- 4.4%
- Average of that tail
- 6.0%
- Max drawdown (1Y)
- 45.0%
- Below its peak
- 32.5%
Against the market
- Beta vs Nifty 50
- 1.02
- Correlation
- 0.29
- Relative strength (3M)
- +0.3%
- ATR (14)
- 4.3%
Return
- Return 1M
- +2.6%
- Return 3M
- +4.1%
- Return 6M
- +10.3%
- Return 1Y
- —
- vs 200-day average
- -0.6%
Momentum
- RSI (14)
- 53.4
- MACD histogram
- 1.72
- Stochastic %K
- 66.2
- ADX (14)
- 13.2
- +DI / −DI
- 26.4 / 20.5
- Money flow index
- 69.6
Participation
- Delivery (20d avg)
- 33.2%
- vs its 60-day baseline
- -0.5 pts
- Volume vs 20-day
- -0.9σ
- Close vs day's VWAP
- -0.5%
- 52-week position
- 28 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
Piotroski F-Score
5 of 6 tested
- Return on assets positive — passed
- Operating cash flow positive — not testableno cash flow statement for this period
- Return on assets improving — passed
- Cash flow exceeds profit — not testableneeds cash flow and profit against assets
- Debt to assets falling — passed
- Current ratio improving — passed
- No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
- Operating margin improving — passed
- Asset turnover improving — failed
- Free cash flow
- ₹157 Cr
- FCF yield
- 0.8%
- Net debt
- -₹996 Cr
- Net debt / equity
- -0.17
- EV / sales
- 6.21
- PEG
- 0.22
- Revenue CAGR
- 24.0%
- Profit CAGR
- 546.1%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Insider trades
| Person | Type | Shares | Value | Disclosed |
|---|---|---|---|---|
Saurabh Sharma Market Sale | Sell | 8,995 | ₹21.5 L | 2 Jan 2026 |
Anand Kuppuswamy Market Sale | Sell | 95,000 | ₹2.3 Cr | 2 Jan 2026 |
Shankar Balan Market Sale | Sell | 29,117 | ₹69.5 L | 2 Jan 2026 |
Swarnendu Mukherjee | Pledge released | 1,00,616 | ₹7.1 Cr | 30 Dec 2025 |
Swarnendu Mukherjee Market Sale | Sell | 26,021 | ₹63.3 L | 30 Dec 2025 |
Shankar Balan Market Sale | Sell | 8,263 | ₹19.7 L | 30 Dec 2025 |
K N Kailash Market Sale | Sell | 7,654 | ₹17.9 L | 30 Dec 2025 |
Sami Afsar Market Sale | Sell | 17,000 | ₹41.1 L | 30 Dec 2025 |
K N Kailash Market Sale | Sell | 2,200 | ₹5.4 L | 30 Dec 2025 |
Swarnendu Mukherjee Market Sale | Sell | 90,000 | ₹2.2 Cr | 26 Dec 2025 |
Shankar Balan Market Sale | Sell | 8,500 | ₹20.0 L | 26 Dec 2025 |
Saurabh Sharma Market Sale | Sell | 8,494 | ₹19.9 L | 26 Dec 2025 |
Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.
Corporate actions
Company announcements
As per the enclosed file
As per enclosed file
Pine Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve As per enclosed file
As per the enclosed file
As per the enclosed file
As per the enclosed file.
As per the enclosed file.
As per the enclosed file
As per the enclosed file.
As per the enclosed file
As per enclosed file
As per the attached file
As per the enclosed file
As per the enclosed file.
As per the enclosed file
Filed with BSE (scrip 544606); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Aug 2026TranscriptSlidesRecording
- Jun 2026TranscriptSlidesRecording
- May 2026Slides
- Feb 2026TranscriptSlidesRecording
- Dec 2025TranscriptSlidesRecording
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 29 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Pine Labs: common questions
Answered from the figures on this page.